FDA-filed SPL labeling · retrieved through openFDA

Pregabalin

Pregabalin is a prescription medicine used to treat nerve pain, fibromyalgia, and partial-onset seizures across several brand and generic products.

Brand names Lyrica CRLyricaBonqat
Rx Schedule CV Forms 3 Route Oral
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 233 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveApr 15, 2025
Clinical labels in scope ⓘ233
AvailabilityRx
Earliest approval/marketing year ⓘ2004
FDA-listed product records ⓘ1,326
Boxed warningNone found in compared labels
How we combine label and product data →
✓No current FDA shortage listed · checked Sep 24, 2026 🚨Recall on record
⭐ Pregabalin at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Pregabalin is an effective option for managing diabetic nerve pain, shingles-related nerve pain, fibromyalgia, spinal cord injury pain, and certain seizures, depending on which product is prescribed. The most common side effects — dizziness and drowsiness — are manageable but real, so never drive until you know how it affects you. Never stop this medicine suddenly, and always tell your doctor and pharmacist about every other medicine you take, especially opioids.

📖 Pregabalin: Patient Information Guide

A plain-language walkthrough of Pregabalin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for▾

Pregabalin is used to treat nerve pain, fibromyalgia, and seizures — but which conditions it's approved for depends on the specific product.

  • Neuropathic pain from diabetic peripheral neuropathy (nerve pain from diabetes): All products — Lyrica capsules, Lyrica oral solution, Lyrica CR, pregabalin capsules, pregabalin oral solution, and pregabalin extended-release tablets
  • Postherpetic neuralgia (nerve pain after shingles): All products listed above
  • Fibromyalgia: Lyrica capsules, Lyrica oral solution, pregabalin capsules, and pregabalin oral solution only — NOT Lyrica CR or pregabalin extended-release tablets
  • Neuropathic pain from spinal cord injury: Lyrica capsules, Lyrica oral solution, pregabalin capsules, and pregabalin oral solution only
  • Add-on therapy for partial-onset seizures (patients 1 month and older): Lyrica capsules and Lyrica oral solution only
  • Add-on therapy for partial-onset seizures (patients 17 years and older): Pregabalin capsules and pregabalin oral solution only
  • Not approved for fibromyalgia or seizures: Lyrica CR and pregabalin extended-release tablets — effectiveness has not been established for these uses
⚙️How it works▾

Pregabalin binds tightly to a specific protein on voltage-gated calcium channels in the brain and spinal cord called the alpha-2-delta subunit. By doing this, it appears to reduce the release of pain-signaling chemicals (neurotransmitters) from overactive nerve cells, helping to quiet down the pain signals traveling through the nervous system. It may also work through pain-regulating pathways that run from the brainstem down into the spinal cord. Though it looks chemically similar to GABA — the brain's main calming chemical — pregabalin does not act directly on GABA receptors and works through a different mechanism entirely.

💊How it's taken▾

How you take pregabalin depends on which product you're prescribed. Capsules and oral solution are taken two or three times daily and can be taken with or without food. Lyrica CR and pregabalin extended-release tablets are taken once daily after an evening meal and must be swallowed whole — never split, crushed, or chewed. If you miss a dose of an extended-release tablet in the evening, you can take it before bed with a snack; if you miss the bedtime dose, take it after a morning meal.

  • Never stop pregabalin suddenly — always taper the dose slowly over at least one week
  • Your dose will be adjusted if you have kidney problems, since pregabalin is cleared through the kidneys
  • Older adults may need lower doses due to age-related changes in kidney function
🤒Side effects — in detail▾

The most common side effects of pregabalin tend to be dose-related and usually start shortly after beginning treatment.

  • Dizziness — very common; was the most frequent reason people stopped the drug in clinical trials
  • Drowsiness (somnolence) — also very common, especially at higher doses
  • Dry mouth
  • Swelling in the hands, feet, or legs (peripheral edema)
  • Weight gain
  • Blurred or double vision — usually resolves with continued use
  • Trouble concentrating or thinking clearly
  • Unsteady walking or poor coordination (ataxia)

Seek medical attention right away for serious reactions: throat or face swelling (angioedema), hives or severe skin reactions, new or worsening depression or suicidal thoughts, or any signs of slow or labored breathing.

⚠️Warnings & precautions▾
  • Breathing problems (respiratory depression): Pregabalin can cause serious or even fatal slowing of breathing, especially when combined with opioids or other CNS depressants. This risk also exists — though less commonly — without those combinations.
  • Suicidal thoughts and behavior: Like all anti-seizure medicines, pregabalin increases the risk of suicidal thinking. This risk applies to anyone taking it, regardless of the reason. Watch for mood changes, worsening depression, or unusual behavior and report them to your doctor immediately.
  • Angioedema and severe allergic reactions: Swelling of the face, mouth, throat, or neck can be life-threatening. Stop the medicine and get emergency help right away if this happens.
  • Do not stop suddenly: Abrupt discontinuation can cause withdrawal symptoms (insomnia, nausea, headache, anxiety) and increases seizure risk in people with seizure disorders. Always taper slowly.
  • Dizziness and drowsiness: These are common and can impair your ability to drive or use machinery — be cautious until you know how pregabalin affects you.
  • Swelling and weight gain: Pregabalin can cause fluid retention and weight gain. This is more pronounced when combined with thiazolidinedione diabetes drugs (such as pioglitazone). Use caution in people with heart failure.
🔀What it interacts with▾

Pregabalin itself is unlikely to affect how other drugs are processed by the liver, but it can add to the effects of drugs that slow the brain or nervous system.

  • Opioids (e.g., oxycodone): Increases risk of serious respiratory depression and sedation — both prescribers need to be aware if you take both
  • Benzodiazepines and other CNS depressants (e.g., lorazepam): Worsens thinking and motor coordination when combined
  • Alcohol: Adds to sedation and impairs cognitive and physical functioning
  • Thiazolidinedione diabetes drugs (e.g., pioglitazone, rosiglitazone): Higher rates of swelling and weight gain when combined with pregabalin
  • ACE inhibitors: May increase the risk of angioedema (throat/face swelling) in people already on these blood pressure medicines

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it▾
  • Allergy to pregabalin: Do not take pregabalin if you've had a hypersensitivity reaction to it before — this is a contraindication
  • Kidney problems: Dose must be reduced in anyone with impaired kidney function, since pregabalin is cleared almost entirely by the kidneys
  • Older adults: Kidney function naturally declines with age, so dose adjustment may be needed
  • Pregnancy: Observational data suggest a possible small increase in the risk of birth defects; animal studies showed developmental toxicity at high doses. Discuss risks and benefits carefully with your doctor. A pregnancy registry is available (call 1-888-233-2334).
  • Breastfeeding: Pregabalin passes into breast milk. Due to a potential risk to the infant, breastfeeding is not recommended while taking pregabalin
  • Men trying to father children: Pregabalin may affect sperm characteristics in a small percentage of men; discuss with your doctor
  • Heart failure (NYHA Class III or IV): Use with caution; limited safety data exist for this group
  • Children: Use in children for seizures is specific to Lyrica (capsules and oral solution) for ages 1 month and older; pregabalin capsules are approved for seizures only in patients 17 and older
🚑If you take too much▾

Taking too much pregabalin can cause reduced consciousness, confusion, agitation, anxiety, seizures, and heart rhythm problems. Deaths have been reported — both with pregabalin alone and when combined with other CNS depressants. There is no specific antidote; treatment focuses on supportive care and monitoring. Call a Poison Control Center immediately (1-800-222-1222 in the US) or go to the emergency room. Pregabalin can be partially removed by hemodialysis if needed.

📡Pharmacodynamics — effects in the body▾

Pregabalin reduces the release of pain-signaling chemicals (pro-nociceptive neurotransmitters) from nerve cells in the spinal cord by binding to the alpha-2-delta subunit of calcium channels. This calms the overactive nerve signals that drive chronic nerve pain and may also reduce abnormal electrical activity that contributes to seizures. It does not block sodium channels, is not active at opioid receptors, and does not affect serotonin, dopamine, or noradrenaline reuptake — which distinguishes it from many other pain and mood medications.

🔬Pharmacokinetics — how your body processes it▾

Pregabalin is rapidly and reliably absorbed when taken by mouth, with more than 90% of the dose reaching the bloodstream regardless of dose size. When taken without food, it peaks in the blood within about 1.5 hours; food slows absorption but does not reduce the total amount absorbed. The body clears pregabalin almost entirely through the kidneys — about 90% is excreted unchanged in the urine — with a half-life of roughly 6 hours in people with normal kidney function. Because elimination is so closely tied to kidney function, people with kidney disease or older adults with age-related kidney decline will need dose adjustments; hemodialysis also removes about 50% of pregabalin from the body in 4 hours.

📦How to store it▾

Store at 20° to 25° C (68° to 77° F), excursions permitted between 15° to 30° C (59° to 86° F) .

📄 Written from Pregabalin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

95

Supplements & herbs that interact with Pregabalin

95 supplements and herbal products have documented interactions with Pregabalin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 7
  • Moderate · 73
  • Minor · 15
Every supplement checked against Pregabalin — ranked by severity The full interaction hub: 7 major · 73 moderate · 15 minor · every one linked to its full report. Check Pregabalin against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Pregabalin — the kind of thing our pharmacy team would talk through with you at the counter.

What is pregabalin actually used for? ▾
Pregabalin is used for a few different conditions depending on which product you're taking. Most commonly it's prescribed for nerve pain — either from diabetes (diabetic peripheral neuropathy) or from a past shingles infection (postherpetic neuralgia). Some forms are also approved for fibromyalgia, nerve pain from spinal cord injury, and as an add-on treatment for certain types of seizures. The extended-release versions — Lyrica CR and pregabalin extended-release tablets — are only approved for the nerve pain conditions, not for fibromyalgia or seizures.
Will pregabalin make me feel dizzy or drowsy? ▾
Yes, dizziness and drowsiness are the most common side effects — and they're the main reason some people end up stopping the medication. They tend to show up shortly after you start and are more noticeable at higher doses. Give it a little time, and avoid driving or using machinery until you know how it affects you. If the dizziness or sleepiness is really bothering you, don't just stop the medicine on your own — talk to your doctor about adjusting the dose.
Can I just stop taking pregabalin if I want to quit? ▾
Please don't stop abruptly. Stopping pregabalin suddenly can cause withdrawal symptoms like insomnia, nausea, headache, and anxiety. If you have a seizure disorder, stopping suddenly can also increase your risk of seizures. Your doctor will work out a tapering plan — usually reducing the dose gradually over at least one week — to help you come off it safely.
Is it safe to drink alcohol while taking pregabalin? ▾
It's best to avoid alcohol while taking pregabalin. Both alcohol and pregabalin slow down your nervous system, and combining them makes the drowsiness and coordination problems significantly worse. If you're also taking opioid pain medicines, adding alcohol to the mix raises the risk even further. When in doubt, skip the drink.
What should I watch for that would mean I need to call a doctor or get emergency help? ▾
A few things need urgent attention. If you notice swelling of your face, lips, tongue, or throat — get emergency help immediately, as this can block your airway. If you develop hives, blisters, rash, or trouble breathing shortly after starting the medicine, stop it and call your doctor or go to the ER. And if you or a family member notices new or worsening depression, unusual mood changes, or any thoughts of self-harm, contact your doctor right away. These are rare but real risks that need prompt action.
Is pregabalin safe to take during pregnancy or while breastfeeding? ▾
This is an important question to discuss with your doctor. Studies in pregnant women suggest there may be a small increase in the risk of birth defects, though the findings are not consistent across all studies. In breastfeeding, pregabalin does pass into breast milk, and because of a potential risk to the infant, breastfeeding is generally not recommended while you're taking it. If you're pregnant, planning to become pregnant, or breastfeeding, have an honest conversation with your prescriber so you can weigh the benefits and risks together.
Is Pregabalin available over the counter? ▾
Pregabalin is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
Is Pregabalin a controlled substance? ▾
Yes — Pregabalin is a federally controlled substance (Schedule V) in the United States, so how it is prescribed, refilled and dispensed is regulated by the DEA.
When was Pregabalin first available? ▾
Pregabalin has been available in the United States since at least 2004, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Pregabalin? ▾
Pregabalin is supplied by 99 manufacturers listed in the FDA NDC Directory, including Bryant Ranch Prepack, Aphena Pharma Solutions - Tennessee, LLC, Remedyrepack Inc..

💬 Answers drafted from Pregabalin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Pregabalin comes

Pregabalin is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Capsule

By mouth
Brands Lyrica
How this form is used
What it may be used for
  • Lyrica capsules are approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
  • Lyrica capsules are approved as add-on therapy for partial-onset seizures in patients 1 month of age and older
  • Pregabalin capsules are approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
  • Pregabalin capsules are approved as add-on seizure therapy for patients 17 years of age and older
Important instructions
  • Lyrica and pregabalin capsules may be taken with or without food
  • Doses are typically divided two or three times daily depending on the condition being treated
  • Do not stop taking capsules abruptly — taper gradually over at least one week as directed by your prescriber
  • Dose adjustment is required for adults with reduced kidney function
Available strengths 8 strengths
Show 2 more strengths Show fewer strengths
1,232 FDA-listed product records ⓘ

Extended-release tablet

By mouth
Brands Lyrica CR
How this form is used
What it may be used for
  • Lyrica CR is approved to manage neuropathic pain associated with diabetic peripheral neuropathy
  • Lyrica CR is approved to manage postherpetic neuralgia
  • Pregabalin Extended Release tablets are approved for neuropathic pain from diabetic peripheral neuropathy and postherpetic neuralgia
  • Lyrica CR and Pregabalin Extended Release tablets have NOT been shown to be effective for fibromyalgia or as seizure add-on therapy
Important instructions
  • Lyrica CR and Pregabalin Extended Release tablets are taken once daily after an evening meal
  • Swallow Lyrica CR and Pregabalin Extended Release tablets whole — do not split, crush, or chew them
  • If you miss your evening dose, take it before bedtime with a snack; if you miss the bedtime dose, take it after a morning meal
  • Do not stop extended-release tablets abruptly — taper gradually over at least one week
Available strengths 3 strengths
52 FDA-listed product records ⓘ

Oral solution

By mouth
Brands Lyrica
How this form is used
What it may be used for
  • Lyrica oral solution is approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
  • Lyrica oral solution is approved as add-on therapy for partial-onset seizures in patients 1 month of age and older
  • Pregabalin oral solution is approved for neuropathic pain from diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain
  • Pregabalin oral solution is approved as add-on therapy for partial-onset seizures in patients 1 month of age and older
Important instructions
  • Lyrica and pregabalin oral solution may be taken with or without food
  • Doses are typically divided two or three times daily depending on the condition
  • Do not stop the oral solution abruptly — taper gradually over at least one week
  • Dose adjustment is required for adults with reduced kidney function
Available strengths 1 strength
10 FDA-listed product records ⓘ

📊 Pregabalin across the U.S. market

How Pregabalin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

3
Dose forms ⓘ
99
Manufacturers
4
Brand names
1,326
FDA-listed product records ⓘ
2004
First marketed ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (32) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack9%
Aphena Pharma Solutions - Tennessee, LLC7%
Remedyrepack Inc.6%
Amneal Pharmaceuticals NY LLC4%
Direct_Rx4%
Proficient Rx LP4%
Other makers64%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Pregabalin is used

A general measure of how commonly Pregabalin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Pregabalin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

2,058,308
Medicaid prescriptions filled (Q1–Q4 2025)
$64.9M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Pregabalin prescribed? Of the 1,597 medications we measure, Pregabalin ranks #109 by Medicaid prescriptions — more than 93% of them.

Where Pregabalin ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Pregabalin product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 150 mg oral capsule is the most-dispensed Pregabalin product — about 23% of these Medicaid prescriptions.

pregabalin 150 MG Oral Capsule Most dispensed

468,376 Medicaid prescriptions (Q1–Q4 2025) 23% of Pregabalin prescriptions shown $17.7M gross reimbursement (before rebates) ≈ $38 per prescription (gross)

Summed across the 19 of 283 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483440

pregabalin 75 MG Oral Capsule

398,921 Medicaid prescriptions (Q1–Q4 2025) 19% of Pregabalin prescriptions shown $8.6M gross reimbursement (before rebates) ≈ $22 per prescription (gross)

Summed across the 21 of 313 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483450

pregabalin 100 MG Oral Capsule

376,543 Medicaid prescriptions (Q1–Q4 2025) 18% of Pregabalin prescriptions shown $9.7M gross reimbursement (before rebates) ≈ $26 per prescription (gross)

Summed across the 21 of 277 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483438

pregabalin 50 MG Oral Capsule

287,624 Medicaid prescriptions (Q1–Q4 2025) 14% of Pregabalin prescriptions shown $8.1M gross reimbursement (before rebates) ≈ $28 per prescription (gross)

Summed across the 19 of 281 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483448

pregabalin 200 MG Oral Capsule

243,912 Medicaid prescriptions (Q1–Q4 2025) 12% of Pregabalin prescriptions shown $11.3M gross reimbursement (before rebates) ≈ $46 per prescription (gross)

Summed across the 16 of 186 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483446

pregabalin 300 MG Oral Capsule

126,472 Medicaid prescriptions (Q1–Q4 2025) 6% of Pregabalin prescriptions shown $5.5M gross reimbursement (before rebates) ≈ $43 per prescription (gross)

Summed across the 16 of 186 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483444

pregabalin 25 MG Oral Capsule

114,917 Medicaid prescriptions (Q1–Q4 2025) 6% of Pregabalin prescriptions shown $2.9M gross reimbursement (before rebates) ≈ $25 per prescription (gross)

Summed across the 19 of 187 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 483442

pregabalin 225 MG Oral Capsule

37,333 Medicaid prescriptions (Q1–Q4 2025) 2% of Pregabalin prescriptions shown $798,849 gross reimbursement (before rebates) ≈ $21 per prescription (gross)

Summed across the 12 of 162 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 577127

pregabalin 20 MG/ML Oral Solution

3,110 Medicaid prescriptions (Q1–Q4 2025) <1% of Pregabalin prescriptions shown $192,986 gross reimbursement (before rebates) ≈ $62 per prescription (gross)

Summed across the 3 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 898715

24 HR pregabalin 165 MG Extended Release Oral Tablet

521 Medicaid prescriptions (Q1–Q4 2025) <1% of Pregabalin prescriptions shown $76,397 gross reimbursement (before rebates) ≈ $147 per prescription (gross)

Summed across the 2 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1988974

24 HR pregabalin 330 MG Extended Release Oral Tablet

484 Medicaid prescriptions (Q1–Q4 2025) <1% of Pregabalin prescriptions shown $64,768 gross reimbursement (before rebates) ≈ $134 per prescription (gross)

Summed across the 2 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1988977

24 HR pregabalin 82.5 MG Extended Release Oral Tablet

95 Medicaid prescriptions (Q1–Q4 2025) <1% of Pregabalin prescriptions shown $17,644 gross reimbursement (before rebates) ≈ $186 per prescription (gross)

Summed across the 1 of 11 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1988980

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Pregabalin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 151 of 1,914 listed Pregabalin NDCs with Medicaid activity.

🔍 Compare Pregabalin products

A representative set of FDA-listed product records for Pregabalin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 1,326 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1,326 Pregabalin NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Pregabalin RxCUI 187832 3 dose forms · 13 strengths
  1. Dose form (SCDF) Oral Capsule RxCUI 483437 In current FDA listings
    Clinical drug / strength (SCD) 25 MG RxCUI 483442 50 MG RxCUI 483448 75 MG RxCUI 483450 100 MG RxCUI 483438 150 MG RxCUI 483440 200 MG RxCUI 483446 225 MG RxCUI 577127 300 MG RxCUI 483444
  2. Dose form (SCDF) Oral Solution RxCUI 898714 In current FDA listings
    Clinical drug / strength (SCD) 20 MG/ML RxCUI 898715 50 MG/ML RxCUI 2671054

Look up RxCUI 187832 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Lyrica CR Lyrica Bonqat

🏭 Manufacturers & labelers

Bryant Ranch Prepack 106 Aphena Pharma Solutions - Tennessee, LLC 83 Remedyrepack Inc. 72 Amneal Pharmaceuticals NY LLC 48 Direct_Rx 47 Proficient Rx LP 45 Advanced Rx Pharmacy Of Tennessee, Llc 44 ScieGen Pharmaceuticals, Inc 32 Sun Pharmaceutical Industries, Inc. 31 Novadoz Pharmaceuticals LLC 30 St. Mary's Medical Park Pharmacy 29 Asclemed USA, Inc. 28 Ascend Laboratories, LLC 27 Parke-Davis Div of Pfizer Inc 26 Aurobindo Pharma Limited 25 Eskayef Pharmaceuticals Limited 24 Exelan Pharmaceuticals Inc. 24 Cipla USA, Inc. 24 Quality Care Products, LLC 24 Solco Healthcare US, LLC 24 Dr.Reddys Laboratories Inc 24 Westminster Pharmaceuticals, LLC 24 Alembic Pharmaceuticals Inc. 24 Marksans Pharma Limited 24

…and 16 more on the FDA NDC directory.

RxNorm drug class

Pregabalin belongs to the Gabapentinoids class.

Drug family (ATC) Gabapentinoids

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Apr 15, 2025
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Pregabalin.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Pregabalin after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
233
NDC products indexed
1,326
Distinct labelers/manufacturers represented
99
Linked representative label ⓘ
Viatris Specialty LLC
Linked label effective
Apr 15, 2025
Composite sections available
24
Linked SPL Set ID
d4734e7d-5079-455e-8ff5-8f4539c998a9
Linked SPL Document ID
1c2af07d-faf4-4fc7-b724-c5166746956d
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 233 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Viatris Specialty LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.